| Followers | 3392 |
| Posts | 100822 |
| Boards Moderated | 9 |
| Alias Born | 10/05/2005 |
Thursday, May 07, 2020 4:49:46 AM
China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, which is a type of Traditional Chinese Medicine that has been processed to be ready for use.
Give Me A Follow If You Want To Consistently Find Winners!
Click Here:
https://investorshub.advfn.com/boards/profilea.aspx?user=61470
Please do your own DD...All my posts are my opinion only!
Recent SXTC News
- China SXT Pharmaceuticals, Inc. Announces Share Re-classification • GlobeNewswire Inc. • 03/23/2026 01:00:00 PM
- China SXT Pharmaceuticals, Inc. Announces Share Consolidation • GlobeNewswire Inc. • 01/30/2026 02:00:00 PM
- CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN • GlobeNewswire Inc. • 01/15/2026 02:00:00 PM
- Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) • GlobeNewswire Inc. • 01/13/2026 10:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/13/2026 09:05:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/12/2026 03:50:39 PM
- China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering • GlobeNewswire Inc. • 01/09/2026 07:50:00 PM
- CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT • GlobeNewswire Inc. • 01/08/2026 02:20:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/31/2025 09:01:02 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/17/2025 05:15:19 AM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 11/10/2025 10:02:14 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/10/2025 09:10:25 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2025 01:27:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2025 11:48:22 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/15/2025 05:48:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/16/2025 03:40:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2025 03:30:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/07/2025 11:58:31 AM
